Kestra Medical (KMTS) Holds Q4 FY2026 Earnings Call

Kestra Medical Technologies (KMTS) held its fourth quarter fiscal 2026 earnings call on the afternoon of July 14. Chief Executive Brian Webster and Chief Financial Officer Vaseem Mahboob led the session, which drew questions from analysts at BTIG, BofA Securities, Piper Sandler, Stifel, Wolfe Research, and Wells Fargo.

The call opened with the standard forward-looking statement caution. Management discussed the quarter's financial results and fielded analyst questions. No specific numbers from the quarter were read during the opening remarks, and the full transcript was not immediately available.

Kestra Medical makes wearable cardiac monitoring and therapy devices. The company went public in 2025. Its next major catalyst is the fiscal 2027 outlook, which will be detailed in the annual report due later this month.

For broader context, see the latest stock market analysis.